_1777294237270_124456903.png&w=64&q=75){kind=small}
Dar Al-Mo'atad Subsidiary Gains Ethamoline Distribution Rights
Dar Al-Mo’ed Medical and Scientific Equipment Company announced that its subsidiary, Qarqas Medical Supplies Trading, has obtained exclusive agency rights to distribute Ethamoline in Saudi Arabia until 2030, in accordance with an agreement with American company QOL Medical, which specializes in rare drugs. Ethamoline is an important medication approved by the U.S. Food and Drug Administration, used to treat bleeding esophageal varices in cases of severe portal hypertension, a critical medical condition requiring precise intervention. This step aims to enhance the drug's presence in the Saudi healthcare sector, support the company's cash flow sustainability, improve its financial results, and complete the registration procedures with the authority to secure a final license in the company's name. This initiative aligns with Saudi Arabia’s Vision 2030 to build an integrated healthcare system and provide high-quality medicines to patients.
Notice: This Is an AI-Generated Summary
Comments (0)